Jump to the main content block
:::
:::
  1. Home

周楠華 publication(en)

周楠華老師

Publications

A. Refereed Papers

  1. Wang YW, Li WM, Wu WJ, Chai CY, Chang TY, Sun Y, Cheng CJ, Shiue YL, Su SJ, Cheng HL, Liu HS, Chow NH. Epithelial membrane protein 2 is a prognostic indicator for patients with urothelial carcinoma of the upper urinary tract. Am J Pathol 183: 709-19, 2013.
  2. Yeh CY, Shin SM, Yeh HH, Wu TJ, Shin JW, Chang TY, Giri R, Lee CT, Chiang JH, Tseng SM, Lee YC, Shen CH, Chow NH(Co-coresponding author), Liu HS: Transcriptional activation of the Axl and PDGFR-alpha by c-Met through a ras- and Src-independent mechanism in human bladder cancer. BMC Cancer 11:139, 2011. (Highly accessed)
  3. Liu HS, Hsu PY, Lai MD, Chang HY, Ho CL, Cheng HL, Chen HT, Lin YJ, Wu TJ, Tzai TS, Chow NH: An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells. Carcinogenesis 31: 1456-1564. 2010.
  4. Ho CL, Tzai TS, Chen JC, Tsai HW, Cheng HL, Eisenberger CF, Chow NH: The molecular signature for urothelial carcinoma of the upper urinary tract. J Urol 179: 1155-1159, 2008. 
  5. Hsu PY, Liu HS, Ho CL, Cheng HL, Tzai TS, Chang TY, Guo HR, Chow NH: Collaboration of RON and EGFR in human bladder carcinogenesis. J Urol 176(5): 2262-2267, 2006.
  6. Cheng HL, Liu HS, Lin YJ, Chen HW, Hsu PY, Chang TY, Ho CL, Tzai TS, Chow NH: Co-expression of RON and MET is a prognostic indicator for patients with transitional cell carcinoma of the bladder. Br J Cancer 9(10) 1906-1914, 2005.
  7. Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, Liu HS, Cheng HL, Hsu PY, Chow NH: The Novel Targets for Anti-angiogenesis of Genistein on Human Cancer Cells. Biochem Pharmacol 69: 307-318, 2005.
  8. Tzai TS, Tsai YS, Chow NH: The prevalence and clinicopathologic correlate of p16INK4, Retinoblastoma, and p53 immunoreactivity in locally advanced urinary bladder cancer. Urol Oncol 22(2):112-118, 2004.
  9. Tzai TSi, Chen HW, Chan SH, Ho CL, Tsai YS, Cheng HL, Dai YC, Lin SN, Yang WH, Chow NH: Clinical significance of allelotype profiling for urothelial carcinoma. Urology 62: 378-384, 2003.
  10. Cheng HL, Trink B, Tzai TS, Liu HS, Chan SH, Ho CL, Sidransky D, Chow NH: Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder. A comparison with p53 nuclear accumulation. J Clin Oncol 20(60): 1544-1550, 2002.
  11. Chow NH, Chan SH, Tzai TS, Ho CL, Liu HS: Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. Clin Cancer Res 2001 7:1957-1962, 2001.
  12. Su SJ, Lai MD, Yeh TM, Chow NH: Overexpression of HER-2/neu enhances sensitivity of human bladder cancer cells to urinary isoflavones. Eu J Cancer 37:1413-1418, 2001.
  13. Huang SM, Lee JC, Wu TJ, Chow NH: Clinical relevance of vascular endothelial growth factor for thyroid neoplasms. World J Surg 25: 302-306,2001.
  14. Lee JC, Lin YJ, Chow NH, Wang ST: Reappraisal of the role of NM23-H1 in colorectal cancers. J Surg Oncol 76: 58-62, 2001.
  15. Cheng HL, Tong YC, Tzai TS, Weng CL, Ho CL, Yang WH, Lin Jonny SN, Chow NH: Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract. Oncol Rep, 8: 193-196, 2001.
  16. Chow NH, Cairns P, Eisenberger CF, Schoenberg MP, Taylor DC, Epstein JI, Sidransky D: Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer. Int J Cancer 89(6): 514-518, 2000.
  17. Chow NH, Liu HS, Chan SH: The role of nm23-H1 in the progression of transitional cell bladder cancer. Clin Cancer Res 6(3): 3595-3599, 2000.
  18. Su SJ, Yeh TM, Lei HY, Chow NH: The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res 6(1): 230-236, 2000.
  19. Chow NH, Tzai TS, Cheng HL, Liu HS, Chan SH, Tong YC: The clinical value of p21WAF1/CIP1 expression in superficial bladder cancer. Anticancer Res 20(1): 1173-1176, 2000.
  20. Eisenberger CF, Schoenberg M, Enger C, Hortopan S, Shah S, Chow NH, Marshall FF, Sidransky D: Diagnosis of renal cancer by molecular urinalysis. J Natl Cancer Inst 91 (23): 2028-2032, 1999.
  21. Docimo SG., Chow NH, Steiner G,. Silver RI, Rodriguez R, Kinsman S, Sidransky D: Schoenberg M. Detection of adenocarcinoma by urinary microsatellite analysis after augmentation cystoplasty. Urology 54(3):561, 1999.
  22. Chow NH, Liu HS, Chan SH, Cheng HL, Tzai TS: Expression of vascular endothelial growth factor in primary superficial bladder cancer. Anticancer Res 19 (5C): 4593-4598, 1999.
  23. Eisenberger CF, Walsh PC, Eisenberger MA, Chow NH, Partin AW, Mostwin JL, Marshall FF, Epstein JI, Schoenberg MP: Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer. Urology 53(1): 175-179, 1999.
  24. Chow NH, Cheng CJ, Chi YC, Liu HS, Tzai TS, Lin JSN: Potential value of urinary intercellular adhesion molecule-1 determination in patients with bladder cancer. Urology 52(6): 1015-1019, 1998.
  25. Baker LA, Chow NH, Docimo SG, Gearhart JP, Sidransky D, Schoenberg MP: Microsatellite deoxyribonucleic acid analysis to detect bladder cancer in bladder extrophy. J Urol 160 (6 Pt 1): 2192-2193, 1998.
  26. Tzai TS, Chow NH, Lin JSN, Yang WH, Tong YC: The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role on the outcome of postoperative intravesical chemotherapy. Anticancer Res 18 (6B): 4717-4722, 1998.
  27. Tzai TS, Shiau AL, Wu CL, Chow NH, Tsai YS: Modulating antitumor immunity of MBT-2 murine bladder tumor bearing mice by postoperative administration of interferon-α. Anticancer Res 18 (5A): 3355-3362, 1998.
  28. Chow NH, Liu HS, Chang CJ, Chi YC, Tzai TS, Li IC, Lin JSN: Urinary excretion of transforming growth factor-alpha in patients with transitional cell carcinoma. Anticancer Res 18 (3B): 2053-2058, 1998.
  29. Chow NH, Guo YL, Lin SN, Su HJ, Tzai TS, Guo HR, Su IJ: Clinicopathologic features of bladder cancer associated with chronic exposure to arsenic. Br J Cancer 75(11): 1708-1710, 1997.
  30. Cheng HL, Chow NH, Tzai TS, Tong YC, Lin SN, Chan SH, Yang WH, Chang CC, Lin YM: Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract. Anticancer Res 17(4A): 2789-2794, 1997.
  31. Chow NH, Liu HS, Yang HB, Chan SH, Su IJ: Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study. Virchows Archiv 430(6): 461-466, 1997.
  32. Chow NH, Liu HS, Lee IC, Chang CJ, Chan SH, Cheng HL, Tzai TS, Lin SN: Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res 172B: 1293-1296, 1997.
  33. Tzai TS, Lin SN, Chow NH: Modulation of the antitumor immunity of tumor bearing mice with low-dose cyclophosphamide. J Surg Res 65(2): 139-144, 1996.
  34. Lee SH, Lin SN, Tzai TS, Chow NH, Tong YC, Yang WH, Chang CC, Cheng HL: Prognostic factors of primary transitional cell carcinoma of the upper urinary tract. Eur Urol 29(3): 266-271, 1996
  35. Chow NH, Chang CJ, Yeh TM, Chan SH, Tzai TS, Lin SN: Implications of urinary basic fibroblast growth factor excretion in patients with urothelial carcinoma. Clin Sci 90(2): 127-133, 1996.
  36. Chow NH, Chang CJ, Cheng PE, Tzai TS, Huang CM, Lin SN: Clinical significance of urinary ferritin excretion in patients with transitional cell carcinoma. Clin Sci 88(6): 701-6, 1995.
  37. Chow NH, Tzai TS, Cheng PE, Chang CJ, Lin SN, Tang MJ: An assessment of immunoreactive epidermal growth factor in urine of patients with urological diseases. Urol Res 22 (4): 221- 5, 1994.
  38. Chow NH, Tzai TS, Lin SN, Su WC, Cheng HL: Near-diploid transitional cell carcinoma: a preliminary report. Int Urol Nephrol 26(4): 423-30, 1994.
  39. Chow NH, Tzai TS, Cheng HL, Chan SH, Lin SN: Urinary cytodiagnosis. Can it have a different prognostic implication than a diagnostic test? Urol Int 53(1): 18-23, 1994.
  40. Tzai TS, Lin SN, Chow NH: Effects of chemoimmunotherapy with and without surgery in murine MBT-2 bladder tumor. Urol Int 53(1): 6-11, 1994.
  41. Lee SE, Chow NH, Chi YC, Tzai TS, Yang WH, Lin SH: Expression of c-erbB-2 protein in normal and neoplastic urothelium: Lack of adverse prognostic effect in human urinary bladder cancer. Anticancer Res 14(3B): 1317-24, 1994.
  42. Chow NH, Tzai TS, Lin SN,Chan SH,Tang MJ: Reappraisal of the biological role of epidermal growth factor receptor (EGFR) in transitional cell carcinoma. Eur Urol 24 (1): 140-3, 1993.
Click Num:
Add to Favorites
Print
Login Success